Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-03-12 @ 5:40 PM
Study NCT ID:
NCT01630850
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2012-06-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Islet Transplantation in Patients With "Brittle" Type I Diabetes
Sponsor:
University of Chicago
Organization:
Study Overview
Official Title:
Islet Transplantation in Patients With "Brittle" Type I Diabetes
Status:
RECRUITING
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: